SCHEMBL1022236

SCHEMBL1022236

COC(=O)C1C(C)CCN1[C@@H](C)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP1A2 P05177 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
KMT2A Q03164 1/20 0.41
HTR1A P08908 2/20 0.40
CHRM2 P08172 3/20 0.40
CHRM4 P08173 3/20 0.40
CHRM5 P08912 3/20 0.40
CHRM1 P11229 3/20 0.40
CHRM3 P20309 3/20 0.40
MAPT P10636 1/20 0.40
CCR5 P51681 1/20 0.39
KDM4E B2RXH2 1/20 0.39
OPRM1 P35372 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1022238 1.00 CYP2D6 (0.42) CYP2D6CYP3A4CYP1A2TSHRMAPK1
SCHEMBL6079535 0.86 KMT2A (0.43) CYP2D6ALDH1A1KMT2ACHRM2CHRM4
SCHEMBL943708 0.86 KMT2A (0.43) CYP2D6ALDH1A1KMT2ACHRM2CHRM4
SCHEMBL27156366 0.86 KMT2A (0.43) CYP2D6ALDH1A1KMT2ACHRM2CHRM4
SCHEMBL29819789 0.86 ALDH1A1 (0.50) CYP3A4CYP1A2TSHRALDH1A1MEN1
SCHEMBL29820127 0.86 ALDH1A1 (0.50) CYP3A4CYP1A2TSHRALDH1A1MEN1
SCHEMBL12480223 0.84 TSHR (0.44) CYP2D6CYP3A4CYP1A2TSHRALDH1A1
SCHEMBL2703180 0.83 OPRK1 (0.43) CYP2D6ALDH1A1KMT2ACHRM2CHRM4
SCHEMBL943677 0.83 OPRK1 (0.43) CYP2D6ALDH1A1KMT2ACHRM2CHRM4
SCHEMBL1075333 0.83 OPRK1 (0.43) CYP2D6ALDH1A1KMT2ACHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448935-A1 SUBSTITUTED 2-CARBOXAMIDE CYCLOAMINO UREAS Novartis AG (CH) 2012-05-09 EP disclosed
WO-2011000905-A1 SUBSTITUTED 2-CARBOXAMIDE CYCLOAMINO UREAS NOVARTIS AG (CH) 2011-01-06 WO disclosed